drugset
drugset / Trial / NCT06752590

A Clinical Study of ONO-1110 in Patients With Fibromyalgia

NCT06752590 ↗

Phase 2 Completed 175 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia

Timeline

Start
2025-03-26
Primary completion
2026-05-30
Completion
2026-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ONO-1110 Unknown — —

Indications

fibromyalgia